Derek J. Hausenloy

44.6k total citations · 14 hit papers
336 papers, 29.8k citations indexed

About

Derek J. Hausenloy is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Emergency Medicine. According to data from OpenAlex, Derek J. Hausenloy has authored 336 papers receiving a total of 29.8k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Pathology and Forensic Medicine, 125 papers in Cardiology and Cardiovascular Medicine and 100 papers in Emergency Medicine. Recurrent topics in Derek J. Hausenloy's work include Cardiac Ischemia and Reperfusion (170 papers), Cardiac Arrest and Resuscitation (100 papers) and Anesthesia and Neurotoxicity Research (71 papers). Derek J. Hausenloy is often cited by papers focused on Cardiac Ischemia and Reperfusion (170 papers), Cardiac Arrest and Resuscitation (100 papers) and Anesthesia and Neurotoxicity Research (71 papers). Derek J. Hausenloy collaborates with scholars based in United Kingdom, Singapore and United States. Derek J. Hausenloy's co-authors include Derek M. Yellon, Sang‐Bing Ong, Sean M. Davidson, Andrew Tsang, Shiang Y. Lim, Mihaela Mocanu, Rainer Schulz, Péter Ferdinandy, Gerd Heusch and Heerajnarain Bulluck and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Derek J. Hausenloy

325 papers receiving 29.3k citations

Hit Papers

Myocardial Reperfusion Injury 2003 2026 2010 2018 2007 2013 2010 2003 2018 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Myocardial Reperfusion Injury
    2007 3.0k citations Derek M. Yellon, Derek J. Hausenloy profile →
  2. Myocardial ischemia-reperfusion injury: a neglected therapeutic target
    2013 1.7k citations Derek J. Hausenloy, Derek M. Yellon profile →
  3. Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
    2010 818 citations Sang‐Bing Ong, Shiang Y. Lim et al. Circulation profile →
  4. New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
    2003 808 citations Derek J. Hausenloy Cardiovascular Research profile →
  5. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities
    2018 642 citations Sang‐Bing Ong, Sauri Hernández‐Reséndiz et al. profile →
  6. Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase-Akt Pathway
    2004 542 citations Derek J. Hausenloy, Derek M. Yellon et al. profile →
  7. Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury
    2019 521 citations Sean M. Davidson, Péter Ferdinandy et al. profile →
  8. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial
    2007 512 citations Derek J. Hausenloy, Vinod Venugopal et al. profile →
  9. Evaluation of Techniques for the Quantification of Myocardial Scar of Differing Etiology Using Cardiac Magnetic Resonance
    2011 493 citations Derek J. Hausenloy, Cono Ariti et al. profile →
  10. Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery
    2015 490 citations Derek J. Hausenloy, Luciano Candilio et al. profile →
  11. Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning
    2014 462 citations Péter Ferdinandy, Derek J. Hausenloy et al. Pharmacological Reviews profile →
  12. Ischaemic conditioning and reperfusion injury
    2016 426 citations Derek J. Hausenloy, Derek M. Yellon profile →
  13. Myocardial reperfusion injury: looking beyond primary PCI
    2013 320 citations Derek M. Yellon, Derek J. Hausenloy et al. profile →
  14. Mitochondria in acute myocardial infarction and cardioprotection
    2020 229 citations Chrishan J. A. Ramachandra, Sauri Hernández‐Reséndiz et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek J. Hausenloy United Kingdom 84 14.9k 10.0k 9.4k 6.9k 5.3k 336 29.8k
Gerd Heusch Germany 94 12.6k 0.8× 7.9k 0.8× 14.2k 1.5× 6.6k 1.0× 4.5k 0.8× 538 30.8k
Derek M. Yellon United Kingdom 108 23.5k 1.6× 14.6k 1.5× 12.0k 1.3× 11.7k 1.7× 8.4k 1.6× 507 42.5k
Roberto Bolli United States 98 13.0k 0.9× 12.0k 1.2× 10.4k 1.1× 5.7k 0.8× 3.2k 0.6× 416 32.7k
Rainer Schulz Germany 78 8.0k 0.5× 7.8k 0.8× 8.1k 0.9× 3.9k 0.6× 2.3k 0.4× 399 22.4k
James M. Downey United States 74 13.3k 0.9× 4.4k 0.4× 5.6k 0.6× 7.6k 1.1× 4.7k 0.9× 272 19.0k
Robert B. Jennings United States 53 11.2k 0.8× 4.6k 0.5× 9.3k 1.0× 5.1k 0.7× 3.1k 0.6× 134 21.4k
Michel Ovize France 56 6.7k 0.5× 3.5k 0.4× 4.1k 0.4× 3.7k 0.5× 2.7k 0.5× 232 12.5k
Masafumi Kitakaze Japan 74 3.8k 0.3× 6.1k 0.6× 8.2k 0.9× 1.7k 0.2× 1.1k 0.2× 474 19.4k
Charles Steenbergen United States 72 5.7k 0.4× 7.4k 0.7× 4.9k 0.5× 2.0k 0.3× 1.0k 0.2× 206 16.5k
Masatsugu Hori Japan 91 3.1k 0.2× 10.7k 1.1× 11.3k 1.2× 1.2k 0.2× 1.3k 0.2× 537 33.2k

Countries citing papers authored by Derek J. Hausenloy

Since Specialization
Citations

This map shows the geographic impact of Derek J. Hausenloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek J. Hausenloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek J. Hausenloy more than expected).

Fields of papers citing papers by Derek J. Hausenloy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek J. Hausenloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek J. Hausenloy. The network helps show where Derek J. Hausenloy may publish in the future.

Co-authorship network of co-authors of Derek J. Hausenloy

This figure shows the co-authorship network connecting the top 25 collaborators of Derek J. Hausenloy. A scholar is included among the top collaborators of Derek J. Hausenloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek J. Hausenloy. Derek J. Hausenloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cour, Martin, Sarah Pedretti, Frederic Nduhirabandi, et al.. (2024). Interplay between the SAFE and the sphingolipid pathway for cardioprotection. Life Sciences. 358. 123145–123145.
2.
Talaei, Mohammad, et al.. (2024). Consumption of different types of meat and the risk of chronic limb-threatening ischemia: the Singapore Chinese Health Study. Nutrition Journal. 23(1). 103–103. 1 indexed citations
3.
Kleinbongard, Petra, Carlos Galán‐Arriola, Lina Badimón, et al.. (2024). The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning. Basic Research in Cardiology. 119(6). 893–909. 4 indexed citations
4.
Kularatna, Sanjeewa, Annie Lee, Yee How Lau, et al.. (2024). Health Services Costs of Clinical Heart Failure With Reduced Ejection Fraction in Singapore. Value in Health Regional Issues. 45. 101037–101037. 1 indexed citations
5.
Sweeney, Mark, Michael S. Lee, Henrike Maatz, et al.. (2024). Interleukin 11 therapy causes acute left ventricular dysfunction. Cardiovascular Research. 120(17). 2220–2235. 1 indexed citations
6.
Ferdinandy, Péter, Ioanna Andreadou, Gary F. Baxter, et al.. (2022). Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning. Pharmacological Reviews. 75(1). 159–216. 81 indexed citations
7.
Schumacher, David, Adelina Curaj, Benjamin Rolles, et al.. (2021). Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling. International Journal of Molecular Sciences. 22(9). 4401–4401. 16 indexed citations
8.
Sia, Ching‐Hui, Huili Zheng, Andrew Fu Wah Ho, et al.. (2020). The Lipid Paradox is present in ST-elevation but not in non-ST-elevation myocardial infarction patients: Insights from the Singapore Myocardial Infarction Registry. Scientific Reports. 10(1). 6799–6799. 24 indexed citations
9.
Ong, Sang‐Bing, Sang‐Bing Ong, Nur Izzah Ismail, et al.. (2018). Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury. Expert Opinion on Therapeutic Targets. 22(3). 247–261. 87 indexed citations
10.
Campbell‐Washburn, Adrienne, Héctor A. Cabrera-Fuentes, Heerajnarain Bulluck, et al.. (2017). Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance. Scientific Reports. 7(1). 2271–2271. 8 indexed citations
11.
Neary, Marianne T., Marthe H. R. Ludtmann, Andrew Hall, et al.. (2014). Hypoxia signaling controls postnatal changes in cardiac mitochondrial morphology and function. Journal of Molecular and Cellular Cardiology. 74. 340–352. 75 indexed citations
12.
Candilio, Luciano, Abdul Malik, Cono Ariti, et al.. (2014). Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial. Heart. 101(3). 185–192. 143 indexed citations
13.
Ong, Sang‐Bing, et al.. (2010). Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury. Circulation. 121(18). 2012–2022. 818 indexed citations breakdown →
14.
Venugopal, Vinod, Chris Laing, Andrew Ludman, Derek M. Yellon, & Derek J. Hausenloy. (2010). Effect of Remote Ischemic Preconditioning on Acute Kidney Injury in Nondiabetic Patients Undergoing Coronary Artery Bypass Graft Surgery: A Secondary Analysis of 2 Small Randomized Trials. American Journal of Kidney Diseases. 56(6). 1043–1049. 86 indexed citations
15.
Hausenloy, Derek J. & Derek M. Yellon. (2008). Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels (Reprinted from Heart, vol 94, pg 706-14, 2008). UCL Discovery (University College London).
16.
Yellon, Derek M. & Derek J. Hausenloy. (2007). Myocardial reperfusion injury - Reply. UCL Discovery (University College London). 3 indexed citations
17.
Yellon, Derek M. & Derek J. Hausenloy. (2007). Mechanisms of disease: Myocardial reperfusion injury. UCL Discovery (University College London). 2 indexed citations
18.
Hausenloy, Derek J. & Derek M. Yellon. (2004). The mitochondrial permeability transition pore in myocardial preconditioning.. UCL Discovery (University College London). 2 indexed citations
19.
Hausenloy, Derek J. & Derek M. Yellon. (2003). Activation of the pro-survival kinases (PI3 kinase-Akt and Erk 1/2) at reperfusion is essential for preconditioning-induced protection. UCL Discovery (University College London). 4 indexed citations
20.
Hausenloy, Derek J., et al.. (2002). Ischemic preconditioning and mitochondrial K-ATP channel activation protect the myocardium by inhibiting mitochondrial permeability transition pore opening. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerd Heusch Breakdown of academic impact, for papers by Derek M. Yellon Breakdown of academic impact, for papers by Roberto Bolli Breakdown of academic impact, for papers by Rainer Schulz Breakdown of academic impact, for papers by James M. Downey Breakdown of academic impact, for papers by Robert B. Jennings Breakdown of academic impact, for papers by Michel Ovize Breakdown of academic impact, for papers by Masafumi Kitakaze Breakdown of academic impact, for papers by Charles Steenbergen Breakdown of academic impact, for papers by Masatsugu Hori
Rankless by CCL
2026